4109
加捷生醫
0.00 (0.00%)11.0095成交張數366.67本益比0.80股價淨值比1.82%殖利率2026-09-11資料日期
毛利率、營業利益率、淨利率
單季;近十年
單季營收
億元
| 季度 | 營收(億) | 營收年增 | 毛利(億) | 毛利率 | 營業利益(億) | 營業利益率 | 淨利率 |
|---|---|---|---|---|---|---|---|
| 2026Q2 | 1.3 | 25.5% | 0.4 | 27.0% | -0.0 | -0.2% | -39.7% |
| 2026Q1 | 1.4 | 1.7% | 0.4 | 28.3% | 0.0 | 2.0% | 13.6% |
| 2025Q4 | 1.3 | 2.6% | 0.3 | 24.7% | -0.1 | -7.5% | 20.4% |
| 2025Q3 | 1.1 | 18.1% | 0.3 | 27.9% | -0.0 | -3.5% | 9.0% |
| 2025Q2 | 1.1 | -29.9% | 0.4 | 35.8% | 0.0 | 3.7% | -0.7% |
| 2025Q1 | 1.3 | -17.0% | 0.5 | 36.0% | 0.1 | 8.1% | 10.1% |
| 2024Q4 | 1.3 | 54.3% | 0.4 | 32.7% | 0.1 | 8.1% | -15.1% |
| 2024Q3 | 1.0 | 15.1% | 0.3 | 32.4% | -0.0 | -0.7% | 3.2% |
| 2024Q2 | 1.5 | 73.7% | 0.5 | 32.2% | 0.1 | 4.5% | 142.0% |
| 2024Q1 | 1.6 | 104.5% | 0.5 | 31.9% | 0.2 | 10.2% | 8.3% |
| 2023Q4 | 0.8 | -3.1% | 0.2 | 23.9% | -0.3 | -30.6% | 190.1% |
| 2023Q3 | 0.8 | -2.6% | 0.3 | 41.7% | -0.0 | -1.1% | 23.0% |
| 2023Q2 | 0.9 | 26.1% | 0.3 | 35.0% | -0.2 | -18.4% | -14.7% |
| 2023Q1 | 0.8 | 2.6% | 0.3 | 41.3% | -0.2 | -30.0% | -29.1% |
| 2022Q4 | 0.9 | 6.7% | 0.3 | 37.3% | -0.0 | -5.1% | -5.0% |
| 2022Q3 | 0.9 | 53.3% | 0.3 | 36.9% | -0.0 | -0.1% | 2.8% |
| 2022Q2 | 0.7 | 34.9% | 0.2 | 36.1% | -0.1 | -9.3% | -2.1% |
| 2022Q1 | 0.8 | 41.3% | 0.3 | 36.2% | -0.0 | -3.6% | -2.7% |
| 2021Q4 | 0.8 | 5.5% | 0.3 | 36.8% | 0.1 | 7.2% | 10.1% |
| 2021Q3 | 0.6 | 2.1% | 0.2 | 32.6% | -0.0 | -5.3% | 0.9% |
| 2021Q2 | 0.5 | -20.0% | 0.2 | 36.8% | -0.0 | -1.4% | -0.8% |
| 2021Q1 | 0.5 | -27.4% | 0.2 | 30.9% | -0.0 | -5.9% | -5.6% |
| 2020Q4 | 0.8 | -10.2% | 0.1 | 16.4% | -0.1 | -16.9% | -12.8% |
| 2020Q3 | 0.5 | -22.0% | 0.2 | 35.0% | -0.0 | -4.0% | 9.3% |
| 2020Q2 | 0.6 | -33.7% | -0.1 | -13.9% | -0.3 | -46.0% | -38.4% |
| 2020Q1 | 0.7 | -17.8% | 0.2 | 25.3% | -0.0 | -4.9% | -3.4% |
| 2019Q4 | 0.9 | -13.0% | 0.1 | 14.1% | -0.2 | -18.7% | -16.5% |
| 2019Q3 | 0.7 | -29.1% | 0.2 | 33.8% | -0.0 | -1.3% | -1.9% |
| 2019Q2 | 1.0 | -9.3% | 0.3 | 29.7% | 0.0 | 1.9% | 1.5% |
| 2019Q1 | 0.9 | -7.8% | 0.2 | 26.0% | -0.1 | -6.0% | -11.4% |
| 2018Q4 | 1.0 | -30.6% | 0.2 | 23.8% | -0.1 | -14.3% | 40.9% |
| 2018Q3 | 1.0 | -11.6% | 0.3 | 32.1% | -0.0 | -1.1% | -0.1% |
| 2018Q2 | 1.1 | -14.0% | 0.3 | 29.3% | -0.1 | -9.3% | -25.9% |
| 2018Q1 | 1.0 | -31.8% | 0.2 | 24.0% | -0.2 | -17.4% | -10.6% |
| 2017Q4 | 1.4 | -1.0% | 0.0 | 1.5% | -0.6 | -40.8% | -144.5% |
| 2017Q3 | 1.1 | -5.1% | 0.4 | 34.1% | -0.1 | -11.4% | -16.9% |
| 2017Q2 | 1.2 | -27.9% | 0.4 | 32.2% | -0.0 | -0.0% | -8.2% |
| 2017Q1 | 1.4 | -25.4% | 0.5 | 36.1% | 0.1 | 8.2% | 2.3% |
| 2016Q4 | 1.4 | – | 0.5 | 31.4% | -0.0 | -0.9% | 4.1% |
| 2016Q3 | 1.2 | – | 0.4 | 37.7% | 0.0 | 1.5% | -4.7% |